Avelas Biosciences

Avelas Biosciences

Innovative intraoperative cancer detection with AVB 620, enhancing surgical precision and patient outcomes. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€73—109m (Dealroom.co estimates Aug 2016.)
San Diego California (HQ)
Authorizing premium user...